6
Tetrahedron Letters
2. S. I. Grivennikov, F. R. Greten, M. Karin, Cell, 2010, 140, 883.
3. (a) M. Kita, B. Gise, A. Kawamura, H. Kigoshi, Tetrahedron Lett.
54 (2013) 6826; (b) M. Zhang, T. Sunaba, Y. Sun, K. Sasaki, H.
Isoda, H. Kigoshi, M. Kita, Chem. Commun. 55 (2019) 5471.
4. A. H. Gentry, Flora Neotropica 25 (1992) 52.
5. M. S. Gachet, W. Schuehly, J. Ethnopharmacol. 121 (2009) 14.
6. A. E. Areces–Mallea, The IUCN Red List of Threatened Species,
e.T35577A9935791 (1998).
7. (a) M. Ogura, G. A. Cordell, N. R. Farnsworth, Lloydia 39 (1976)
255; (b) M. Ogura, G. A. Cordell, N. R. Farnsworth, Lloydia 40
(1977) 157.
8. (a) F. Bohlmann, A. Suwita, Chem. Ber. 109 (1976) 2014; (b) F.
Bohlmann, C. Zdero, M. Grenz, Chem. Ber. 110 (1977) 474.
9. B. M. Fraga, C. E. Diaz, L. J. Amador, M. Reina, O. Santana, A.
Gonzalez–Coloma, Phytochemistry 108 (2014) 220.
10. F. Bohlmann, K. H. Knoll, Phytochemistry 17 (1978) 557.
11. J. Jakupovic, T. V. Chau–Thi, V. Castro, Fitoterapia 58 (1987)
187.
mechanism includes the generation of reactive oxygen species
(ROS), which causes downregulation of Akt, activation of p38
mitogen-activated protein kinase (MAPK), and induction of
Bax expression. p38 MAPK influences a variety of cellular
systems, such as cell growth and death, cell proliferation,
differentiation, and inflammation [39]. Inhibition of p38
MAPK decreases the expression of TNF-, a proinflammatory
cytokine that widely mediates inflammatory responses and
innate immunity. TNF- is responsible for a variety of
diseases, such as cancer, sepsis, rheumatoid arthritis, diabetes
and inflammation [40]. Meanwhile, we demonstrated that 1
inhibited TNF- production both in vitro and in vivo, and its
effective concentrations were lower than those in apoptotic
cells. There are significant differences between different cell
types regarding the roles of p38 MAPK in TNF- synthesis
[41]. In fact, the p38 MAPK pathway in human neutrophils is
inhibited by melodamide A [26]. Thus, the anti-inflammatory
activity of 1 in LPS-treated murine macrophages might not be
related to p38 MAPK activation in apoptosis.
12. P. Gonser, J. Jakupovic, G. Crou, L. Vincent, Phytochemistry 29
(1990) 3940.
13. A. L. Perez–Castorena, A. Arciniegas, F. Martinez, C. Marquez, J.
L. Villasenor, A. Romo de Vivar, Biochem. Syst. Ecol. 29 (2001)
203.
14. (a) T. R. Morais, P. Romoff, O. A. Favero, J. Q. Reimao, W. C.
Lourenco, A. G. Tempone, A. D. Hristov, S. M. Di Santi, J. H. G.
Lago, P. Sartorelli, M. J. P. Ferreira, Parasitology Res. 110 (2012)
95; (b) M. H. Massaoka, A. L. Matsuo, C. R. Figueiredo, C. F.
Farias, N. Girola, D. C. Arruda, J. A. B. Scutti, P. Romoff, O. A.
Favero, M. J. P. Ferreira, J. H. Lago, L. R. Travassos, PLoS One 7
(2012) e38698.
15. N. Mezache, S. Derbre, H. Laouer, P. Richomme, D. Seraphin, S.
Akkal, Nat. Prod. Res. 33 (2019) 2182.
16. P. Muhammad, S. Ahmad, H. R. Nawaz, N. Ullah, A. Malik,
Fitoterapia 70 (1999) 229.
SAR studies of jacaranones also revealed that their high
electrophilicity as Michael acceptors was important for their
potent anti-inflammatory activity. It has been shown that
incubation of 1 with glutathione (GSH) and rat liver GSH S-
transferase provides mono- or bis-GSH adducts [23]. A high
dose of 1 caused death in mice (LD50 = 150~200 mg/kg, i.p.),
and this effect was explained by GSH depletion in the liver.
Meanwhile, several electrophiles containing -enones, such as
the IB kinase and NF-B inhibitor 15-deoxy-12,14
-
17. Y. Jo, J. Suh, M. H. Shin, J. H. Jung, K. S. Im, Arch. Pharm. Res.
28 (2005) 885.
prostaglandin J2 [42], covalently react with cellular
nucleophiles to show a variety of biological responses. These
results suggest that jacaranones may also target specific
biomacromolecule(s) at low concentrations to exhibit anti-
inflammatory or other characteristic activities, and not merely
nonspecifically react with abundant nucleophiles in cells.
Further studies on jacaranones, including identification of their
targets on macrophages using chemical probes prepared from
alkyne 9 and their effects on cellular signaling, are in progress.
18. (a) J. C. Yvin, L. Chevolot, A. M. Chevolot–Magueur, J. C.
Cochard, J. Nat. Prod. 48 (1985) 814; (b) L. Chevolot, J. C.
Cochard, J. C. Yvin, Mar. Ecol. Prog. Ser. 74 (1991) 83.
19. Y. G. Gouda, A. M. Abdel–Baky, F. M. Darwish, K. M.
Mohamed, R. Kasai, K. Yamasaki, Bull. Pharm. Sci. Assiut Univ.
25 (2002) 165.
20. M. R. Loizzo, R. Tundis, G. A. Statti, F. Menichini, Arch. Pharm.
Res. 30 (2007) 701.
21. J. A. Cabezas, J. F. Ciccio, G. Hidalgo, G. Echandi, Rev.
Latinoamer. Quim. 22 (1991) 49.
22. K. de S. Gomes, C. I. Tamayose, M. J. P. Ferreira, C. Murakami,
M. C. M. Young, G. M. Antar, F. F. Camilo, P. Sartorelli, J. H. G.
Lago, Quimica Nova 42 (2019) 156.
23. H. Xu, N. Zhang, J. E. Casida, J. Agric Food Chem. 51 (2003)
2544.
24. M. Sauvain, J. P. Dedet, N. Kunesch, J. Poisson, J. C. Gantier, P.
Gayral, G. Kunesch, Phytotherapy Res. 7 (1993) 167.
25. M. S. Gachet, O. Kunert, M. Kaiser, R. Brun, R. A. Munoz, R.
Bauer, W. Schuhly, J. Nat. Prod. 73 (2010) 553.
26. (a) H.-H. Chan, T.-L. Hwang, T. D. Thang, Y.-L. Leu, P.-C. Kuo,
B. T. M. Nguyet, D. N. Dai, T.-S. Wu, Planta Med. 79 (2013)
288; (b) N. S. Engels, B. Waltenberger, B. Michalak, L. Huynh,
H. Tran, A. K. Kiss, H. Stuppner, Chem. Biodiversity, 15 (2018)
e1800269.
Acknowledgments
We thank Mr. Osamu Takahashi for his cooperation on the
field experiments and sample collection of Cuban plants, Ms.
Toshiko Takenaka for the preparation of plant extracts, and
Ms. Saeka Nishio for her support on animal experiments. This
work is supported in part by JSPS grants (16H05655), JSPS
A3 Foresight Program, The Toyota Foundation, and the Naito
Foundation.
Supplementary data
27. (a) S.-Y. Park, H.-J. Lee, W.-J. Yoon, G.-J. Kang, J.-Y. Moon, N.-
H. Lee, S.-J. Kim, H.-K. Kang, E.-S. Yoo, Arch. Pharm. Res. 28
(2005) 1244; (b) H.-J. Lee, T.-H. Oh, W.-J. Yoon, G.-J. Kang, E.-
J. Yang, S.-S. Park, N.-H. Lee, H.-K. Kang, E.-S. Yoo, J. Pharm.
Pharmacol. 60 (2008) 917.
Supplementary data associated with this article can be
found,
in
the
online
version,
at
http://dx.doi.org/10.1016/j.tetlet.???????.
28. M. E. Callister, L. Pinhu, M. C. Catley, A. D. Westwell, R.
Newton, S. K. Leaver, G. J. Quinlan, T. W. Evans, M. J. Griffiths,
A. Burke–Gaffney, Br. J. Pharmacol. 155 (2008) 661.
29. A. Fischer, G. N. Henderson, Tetrahedron Lett. 24 (1983) 131.
30. Related synthesis of 1: (a) K. A. Parker, J. R. Andrade, J. Org.
Chem. 44 (1979) 3964; (b) D. A. Evans, D. J. Hart, P. M.
Koelsch, P. A. Cain, Pure Appl. Chem. 51 (1979) 1285; (c) S.
References and notes
1. (a) N. Myers, R. A. Mittermeier, C. G. Mittermeier, G. A. B. da
Fonseca, J. Kent, Nature 403 (2000) 853; (b) M. Maunder, A.
Leiva, E. Santiago–Valentin, D. W. Stevenson, P. Acevedo–
Rodriguez, A. W. Meerow, M. Mejia, C. Clubbe, J. Francisco–
Ortega, Bot. Rev. 74 (2008) 197.